EUVIMEDEUVIMED entdecken
Crossref

Chickenpox in pregnancy

Toxicology and Applied Pharmacology Insights · 2023

DOI: 10.33140/tapi.06.01.03 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Toxicology and Applied Pharmacology Insights, 2023.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Varicella, the number one contamination with varicella-zoster virus (VZV; human herpes virus) in pregnancy, might also cause maternal mortality or extreme morbidity. It may also be the cause of fetal varicella syndrome (FVS) and varicella contamination in new children, which incorporates congenital varicella syndrome (CVS) and neonatal varicella. This guiding principle addresses the role of varicella vaccination in women of reproductive ages. The rule also assesses evidence concerning the maternal and fetal risks of VZV contamination in pregnancy and whether these headaches may be prevented or changed beneficially with the aid of the management of varicella-zoster immunoglobulin (VZIG) or with the aid of a remedy for infected people with acyclovir. This fact should manual the prudent use of VZIG, which is made of the plasma of human blood donors and is consequently a restricted and costly aid. The control of neonates is outdoor the scope of this tenet. Guidance on neonatal publicity and disorder is to be had from other sources [1-2]

Zitieren

APA

(2023). Chickenpox in pregnancy. Toxicology and Applied Pharmacology Insights. https://doi.org/10.33140/tapi.06.01.03

Vancouver

Chickenpox in pregnancy. Toxicology and Applied Pharmacology Insights. 2023. doi:10.33140/tapi.06.01.03

BibTeX
@article{euvimed2023,
  title = {Chickenpox in pregnancy},
  journal = {Toxicology and Applied Pharmacology Insights},
  year = {2023},
  doi = {10.33140/tapi.06.01.03}
}
Kostenlos starten →